• Chemicals
• Discovery / R&D
• Generics
• Market Trends
• Pharma Industry Trends
• Pricing & Reimbursement
• Regulatory
• Sales & Marketing
• Therapeutic

M&A in pharma

Explores the merits of mega-deal in contrast to a more measured portfolio growth strategy

National pharmaceutical pricing and reimbursement is a complex and ever-changing area. In a rapidly globalising market it is essential that executives are briefed on the regulatory systems that determine the way in which your company operates and sells its products.

The Guide to Pharmaceutical Pricing and Reimbursement Systems: Western Europe is a straightforward guide to the pricing and reimbursement mechanisms in the major European markets.

The Guide will:

• save you time by concisely explaining the key elements of pricing and reimbursement regulation
• offer insight into latest policies and the political environment
• increase your knowledge of the ways in which governments influence and control the pharmaceutical industry

Each country section has the following headings:

• SummaryHow is the healthcare system structured?
• What size is the pharmaceutical market?
• Are pharmaceuticals taxed?
• How are drug prices set?
• How are prices changed?
• How are drugs reimbursed?
• Is there a payback arrangement?
• Are hospital sales controlled?
• Are OTC prices regulated?
• How are pharmaceutical costs controlled?
• How are generic drugs priced?
• What are wholesale/pharmacy margins?
• Is parallel trade influential?
• What to look out for
• Abbreviations
• Useful Contacts

Key features of this unique book

Easy to use
Standardised headings and full indexing allow you to access the relevant information quickly

Well researched
Extensive use of primary and secondary sources makes the book extremely comprehensive

Up to date
Impending developments are clearly indicated, allowing you to anticipate the changes that will affect you business
Clearly presented
Using a question and answer format, the information is easily digestible

Austria

Belgium

Denmark

Finland

France

Germany

Greece

Ireland

Italy

Netherlands

Norway

Portugal

Spain

Sweden

Switzerland

United Kingdom

List of Figures

Austrian healthcare financing by category in 2002 (?m)
Austrian pharmaceutical market 2001-2003 (?m at consumer price level)*
Health spending in Austria
Increase in pharmaceutical sales of reimbursed drugs Austria
Pharmaceutical price regulation classification in Austria
Number of medicinal products according to classification (1 January 2005)
The registration to reimbursement structure for pharmaceuticals in Austria
Pharmaceutical hospital sales in Austria
Austrian OTC sales
Patient co-payments 2001-2005 (?)
Growth of generics market in Austria (2000-2005)
Wholesale pharmacy margins (2005)
Pharmacy margins for purchasers who receive preferential treatment
Pharmacy margins for private customers
Price structure of medicines in Austria in 2003
Price build-up of pharmaceuticals in Austria - 2005
Changes to the pharmaceutical pricing and reimbursement system in Austria (1995-2005)
Summary of pharmaceutical cost-containment measures in Austria
Healthcare budget in Belgium
Administrative procedures for pharmaceutical pricing and reimbursement
Reimbursement rates by drug category in Belgium
Drug pricing and reimbursement timeline
Healthcare expenditure by drug category
NCE reimbursement premiums in Belgium (2000)
Refused registrations in Chapter I
Summary of patient co-payment criteria in Belgium
The Maximum A Facturer Cap
Price breakdown of pharmaceuticals according to consumer price
Average price build-up of pharmaceuticals
Changes to the drug price and reimbursement system in Belgium (1992-2006)
Summary of pharmaceutical cost-containment measures in Belgium
Danish pharmaceutical market 2002-2004 (?m at consumer price level)*
Sales pharmaceutical specialties, 2001-2005 (pharmacy purchase prices; DKKm)
Number of active substances, medicinal products and packs, on the Danish market 2000-2004
Price development of pharmaceuticals
Reimbursement, co-payment and turnover of pharmaceuticals sold to individuals divided by reimbursement types in the third quarter of 2004
Ongoing medicine reimbursement re-assessment procedure
Sales of medicinal products in the hospital sector 2000-2004 (DKKm)
Annual patient reimbursement levels for prescription medicines
Permitted price variation for generic substitution in Denmark
Pharmacy margins in Denmark - 2002
Price build-up of pharmaceuticals in Denmark - 2005
Price build up of pharmaceuticals, EU average vs. Denmark
Parallel imports in Denmark
Changes to the drug price and reimbursement system in Denmark (1991-2005)
Summary of pharmaceutical cost-containment measures in Denmark
Danish pharmaceutical market 2002-2004 (?m at consumer price level)*
Sales pharmaceutical specialties, 2001-2005 (pharmacy purchase prices; DKKm)
Number of active substances, medicinal products and packs, on the Danish market 2000-2004
Price development of pharmaceuticals
Reimbursement, co-payment and turnover of pharmaceuticals sold to individuals divided by reimbursement types in the third quarter of 2004
Ongoing medicine reimbursement re-assessment procedure
Sales of medicinal products in the hospital sector 2000-2004 (DKKm)
Annual patient reimbursement levels for prescription medicines
Permitted price variation for generic substitution in Denmark
Pharmacy margins in Denmark - 2002
Price build-up of pharmaceuticals in Denmark - 2005
Price build up of pharmaceuticals, EU average vs. Denmark
Parallel imports in Denmark
Changes to the drug price and reimbursement system in Denmark (1991-2005)
Summary of pharmaceutical cost-containment measures in Denmark
Pharmaceutical sales at consumer prices in Finland, 2004
Breakdown of drug sales in 2003
Wholesale price index for all medicines, prescription medicines and self-care medicines compared to the consumer price index, 1998-2003
Wholesale price and special reimbursement status application process
Medicine reimbursement paid by the SII, 2003
Most significant diseases entitling the patient to special reimbursement of medicine costs, 2003
Most significant diseases entitling the patient to special refunds and average cost per recipient, 2004
Drugs granted special reimbursement status in 2004
First year of generic substitution in Finland (April 2003-March 2004)
Pharmacy price bands in Finland - 2003
State-imposed pharmacy fees in Finland - 2003
Figure.12 Price build-up of pharmaceuticals in Finland, 2004
Changes to the drug price and reimbursement system in Finland (1990-2005)
Summary of pharmaceutical cost-containment measures in Finland
Pharmaceutical sales at consumer prices in Finland, 2004
Breakdown of drug sales in 2003
Wholesale price index for all medicines, prescription medicines and self-care medicines compared to the consumer price index, 1998-2003
Wholesale price and special reimbursement status application process
Medicine reimbursement paid by the SII, 2003
Most significant diseases entitling the patient to special reimbursement of medicine costs, 2003
Most significant diseases entitling the patient to special refunds and average cost per recipient, 2004
Drugs granted special reimbursement status in 2004
First year of generic substitution in Finland (April 2003-March 2004)
Pharmacy price bands in Finland - 2003
State-imposed pharmacy fees in Finland - 2003
Price build-up of pharmaceuticals in Finland, 2004
hanges to the drug price and reimbursement system in Finland (1990-2005)
Summary of pharmaceutical cost-containment measures in Finland
European average prices in relation to France
Payback system for companies that have not signed conventions with the CEPS
Fee exemptions per pharmaco-therapeutic aggregate
Tax on promotional spend of pharmaceuticals
Share of generics as a percentage of all medicines sold 1999-2003
Directory of generics as percentage of the market for reimbursable products
Wholesaler and pharmacy margins 2005
Price build-up for an average ?10 non-reimbursable and reimbursable medicinal
Changes to the drug price and reimbursement system in France (1990-2004)
Summary of pharmaceutical cost-containment measures in France
Pharmaceutical industry in Germany (2003): figures and facts
Pharmaceutical sales per capita (2002 in US$ adjusted for purchasing power)
Expenditures in statutory health insurance system (2003)
Sales and packages sold through pharmacies (2003)
Pharmaceutical prices: an international comparison (2003)
Regulatory measures and attractiveness of German generics market (2001)
Pharmacy margins in Germany
Price build-up of lower priced pharmaceuticals in Germany - 2004
Price build-up of higher priced pharmaceuticals in Germany - 2004
Price structure of prescription medicines in Germany vs. Europe - 2001
Parallel Imports in the pharmacy market (at manufacturer's prices)
Changes to the drug price and reimbursement system in Germany (1993-2004)
Summary of pharmaceutical cost-containment measures in Germany
Pharmaceutical industry in Germany (2003): figures and facts
Pharmaceutical sales per capita (2002 in US$ adjusted for purchasing power)
Expenditure


Interested in pharmaceutical pricing and reimbursement issues in these countries, as well as in a focused and related newsflow? Then check the latest available service from URCH Publishing, PharmaceuticalPricing.com

In-house